Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123567632 | 12356763 | 2 | F | 201603 | 20160620 | 20160511 | 20160713 | PER | US-PFIZER INC-2016216637 | PFIZER | 52.00 | YR | M | Y | 90.72000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123567632 | 12356763 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | 3200 MG, DAILY | N | 20882 | 3200 | MG | FILM-COATED TABLET | |||||||
| 123567632 | 12356763 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 900 MG, DAILY | N | 20882 | 900 | MG | FILM-COATED TABLET | |||||||
| 123567632 | 12356763 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | 800 MG, DAILY | N | 20882 | 800 | MG | FILM-COATED TABLET | |||||||
| 123567632 | 12356763 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, DAILY | N | 20882 | 300 | MG | FILM-COATED TABLET | |||||||
| 123567632 | 12356763 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 3X/DAY | N | 20882 | 300 | MG | FILM-COATED TABLET | TID | ||||||
| 123567632 | 12356763 | 6 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 2X/DAY | M83431 | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||||
| 123567632 | 12356763 | 7 | SS | LYRICA | PREGABALIN | 1 | 25 MG, 2X/DAY | M70128 | 21446 | 25 | MG | CAPSULE, HARD | BID | ||||||
| 123567632 | 12356763 | 8 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 2X/DAY | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||||
| 123567632 | 12356763 | 9 | C | ZYPREXA | OLANZAPINE | 1 | 7.5 MG, 1X/DAY | C452845A | 0 | 7.5 | MG | QD | |||||||
| 123567632 | 12356763 | 10 | C | ZYPREXA | OLANZAPINE | 1 | 0 | ||||||||||||
| 123567632 | 12356763 | 11 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 20 MG, 1X/DAY | 160090 | 0 | 20 | MG | QD | |||||||
| 123567632 | 12356763 | 12 | C | DICLOFENAC | DICLOFENAC | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 123567632 | 12356763 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 123567632 | 12356763 | 14 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 17 G, 2X/DAY | 170430 | 0 | 17 | G | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123567632 | 12356763 | 1 | Neuropathy peripheral |
| 123567632 | 12356763 | 6 | Neuropathy peripheral |
| 123567632 | 12356763 | 9 | Sleep disorder |
| 123567632 | 12356763 | 10 | Bipolar disorder |
| 123567632 | 12356763 | 11 | Bipolar disorder |
| 123567632 | 12356763 | 12 | Arthralgia |
| 123567632 | 12356763 | 13 | Seasonal allergy |
| 123567632 | 12356763 | 14 | Constipation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123567632 | 12356763 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123567632 | 12356763 | 5 | 201602 | 0 | ||
| 123567632 | 12356763 | 6 | 201602 | 0 | ||
| 123567632 | 12356763 | 7 | 201603 | 0 | ||
| 123567632 | 12356763 | 8 | 20160404 | 0 | ||
| 123567632 | 12356763 | 9 | 2007 | 0 | ||
| 123567632 | 12356763 | 11 | 2004 | 0 | ||
| 123567632 | 12356763 | 12 | 2013 | 0 | ||
| 123567632 | 12356763 | 13 | 2013 | 0 | ||
| 123567632 | 12356763 | 14 | 2015 | 0 |